This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200308-1171OCv1 169/9/1028    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ong, K.-C. Articles by Wang, Y.-T. Search for Related Content PubMed PubMed Citation Articles by Ong, K.-C. Articles by Wang, Y.-T.

Effects of Inhaled Furosemide on Exertional Dyspnea in Chronic Obstructive Pulmonary Disease

Department of Respiratory Medicine and Clinical Research Unit, Tan Tock Seng Hospital, Singapore

Correspondence and requests for reprints should be addressed to Kian-Chung Ong, M.B.B.S., F.A.M.S., F.R.C.P., Department of Respiratory Medicine, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433. E-mail: kian_chung_ong{at}ttsh.com.sg

The aim of this study is to investigate the effects of inhaled furosemide on the sensation of dyspnea produced during exercise in patients with stable chronic obstructive pulmonary disease (COPD). In a double-blind, randomized, crossover study we compared the effect of inhaled furosemide on dyspneic sensation during exercise testing with that of placebo. Spirometry and incremental and constant-load exercise testing were performed after inhalation of placebo or furosemide on 2 separate days in 19 patients with moderate or severe COPD. Subjects were asked to rate their sensation of respiratory discomfort using a 100-mm visual analog scale. There was significant improvement in mean FEV₁ and FVC after inhalation of furosemide (p = 0.038 and 0.005, respectively) but not after placebo. At standardized exercise time during constant-load exercise testing but not during incremental exercise, the mean dyspneic visual analog scale score was lower after inhalation of furosemide compared with placebo (33.7 ± 25.2 vs. 42.4 ± 24.0 mm, respectively, p = 0.014). We conclude that inhalation of furosemide alleviates the sensation of dyspnea induced by constant-load exercise testing in patients with COPD and that there is significant bronchodilation after inhalation of furosemide compared with placebo in these patients.

Key Words: exercise capacity • bronchodilation • breathlessness • exercise test • spirometry

This article has been cited by other articles:

				A Wilcock, A Walton, C Manderson, L Feathers, B E. Khoury, M Lewis, A Chauhan, P Howard, S Bell, J Frisby, et al. Randomised, placebo controlled trial of nebulised furosemide for breathlessness in patients with cancer Thorax, October 1, 2008; 63(10): 872 - 875. [Abstract] [Full Text] [PDF]

				D Jensen, K Amjadi, V Harris-McAllister, K A Webb, and D E O'Donnell Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD Thorax, July 1, 2008; 63(7): 606 - 613. [Abstract] [Full Text] [PDF]

				P. A. Kvale, P. A. Selecky, and U. B. S. Prakash Palliative Care in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 368S - 403S. [Abstract] [Full Text] [PDF]

				B. J. Undem and M. Kollarik The Role of Vagal Afferent Nerves in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 355 - 360. [Abstract] [Full Text] [PDF]

				L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004 Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 686 - 698. [Full Text] [PDF]